The Hierarchy of Communication Needs: A Novel Communication Strategy for High Mistrust Settings Developed in a Brazilian COVID-ICU

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
MARY ANN LIEBERT, INC
Autores
STOLTENBERG, Mark
ALMEIDA, Ingrid Maria (Mia) Olsen de
JACKSON, Vicki
DAUBMAN, Bethany-Rose
Citação
PALLIATIVE MEDICINE REPORTS, v.5, n.1, p.86-93, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Context: The COVID-19 pandemic presented unique challenges for health care systems. Overcrowded units, extreme illness severity, uncertain prognoses, and mistrust in providers resulted in a ""pressure cooker"" where traditional communication strategies were often insufficient.Objectives: Building on well-studied traditional communication interventions, neurobiology principles were used to create a novel communication strategy designed in the COVID-ICU to respond to the unique communication needs of patients within the context of a high mistrust setting.Methods: The hierarchy of communication needs recognizes three specific levels of communication that are essential within high-emotion and low-trust settings. The first level is to establish trust. The second level is to resonate with patients' emotions, helping to reduce arousal and improve empathy. The third level includes the more traditional content of disclosing prognostic information and shared decision-making. When facing communication challenges, clinicians are taught to move back a level and reattune to emotions and/or reestablish trust.Discussion: The COVID pandemic revealed the shortcomings of a primarily cognitive communication style. The hierarchy of communication needs emphasizes trust building, and emotional resonance as prerequisites of effective cognitive discussions, resulting in more effective clinician-patient communication that more fully incorporates cultural humility and better meets the needs of diverse patient populations. Additional research is needed to further develop this strategy and evaluate its impact on patient experience and outcomes.
Palavras-chave
Brazil, communication, education, global health, intensive care, Latin America, low- and middle-income country, palliative care, shared-decision making
Referências
  1. Atran S, 2007, SCIENCE, V317, P1039, DOI 10.1126/science.1144241
  2. Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271
  3. Busolo David, 2015, JBI Database System Rev Implement Rep, V13, P99, DOI 10.11124/jbisrir-2015-1809
  4. Cain CL, 2018, J PAIN SYMPTOM MANAG, V55, P1408, DOI 10.1016/j.jpainsymman.2018.01.007
  5. de Waal FBM, 2017, NAT REV NEUROSCI, V18, P498, DOI 10.1038/nrn.2017.72
  6. Dölen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518
  7. Elk R, 2021, J LAW MED ETHICS, V49, P222, DOI 10.1017/jme.2021.32
  8. Emanuel EJ, 2004, ARCH INTERN MED, V164, P1999, DOI 10.1001/archinte.164.18.1999
  9. Engelmann JM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2803
  10. Forte DN, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0317-y
  11. Gaur S, 2020, J AM MED DIR ASSOC, V21, P943, DOI 10.1016/j.jamda.2020.05.062
  12. Hallenbeck James, 2006, Am J Hosp Palliat Care, V23, P113, DOI 10.1177/104990910602300208
  13. Harari Y. N., 2015, SAPIENS BRIEF HIST H, DOI 10.4103/JPCS.JPCS_19_17
  14. Jackson VA, 2013, J PALLIAT MED, V16, P894, DOI 10.1089/jpm.2012.0547
  15. Jacobsen J, 2022, JAMA-J AM MED ASSOC, V327, P321, DOI 10.1001/jama.2021.23695
  16. Jacobsen J, 2021, J PALLIAT MED, V24, P1757, DOI 10.1089/jpm.2021.0442
  17. Jacobsen JC, 2020, NEW ENGL J MED, V382, P2450, DOI 10.1056/NEJMcpc2002419
  18. Jarcho JM, 2011, SOC COGN AFFECT NEUR, V6, P460, DOI 10.1093/scan/nsq054
  19. Jennerich AL, 2020, CHEST, V158, P1482, DOI 10.1016/j.chest.2020.05.554
  20. Kandel ER, 2013, PRINCIPLES NEURAL SC
  21. Kennifer SL, 2009, PATIENT EDUC COUNS, V76, P51, DOI 10.1016/j.pec.2008.10.003
  22. Leonard MB, 2022, PEDIATR RES, V91, P482, DOI 10.1038/s41390-021-01866-z
  23. Liu JX, 2019, OCCUP ENVIRON MED, V76, P927, DOI 10.1136/oemed-2019-105849
  24. Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298
  25. Mosher CP, 2014, CURR BIOL, V24, P2459, DOI 10.1016/j.cub.2014.08.063
  26. Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022
  27. Paladino J, 2020, CANCER MED-US, V9, P4550, DOI 10.1002/cam4.3102
  28. Paladino J, 2020, J PALLIAT MED, V23, P337, DOI 10.1089/jpm.2019.0334
  29. Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107
  30. Rosenberg LB, 2022, J PALLIAT MED, V25, P537, DOI 10.1089/jpm.2021.0667
  31. Rosenberg LB, 2021, J PALLIAT MED, V24, P1598, DOI 10.1089/jpm.2021.0240
  32. Siegel D.J., 2010, MINDFUL THERAPIST CL
  33. Stapleton RD, 2006, CRIT CARE MED, V34, P1679, DOI 10.1097/01.CCM.0000218409.58256.AA
  34. Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046
  35. Wittenberg-Lyles EM, 2008, SOC SCI MED, V66, P2356, DOI 10.1016/j.socscimed.2008.01.042